Financial Highlights For the Year Ended 31 December 2025 (HK$ million) 2025 2024 Change Revenue  4,001.1 3,811.9 + 5.0% Gross Profit  1,385.1 1,312.1 + 5.6% Gross Profit margin 34.6% 34.4% + 0.2pp Profit attributable to owners of the Company  331.4 201.0 + 64.9% […]

HONG KONG, Mar 25, 2026 – (ACN Newswire via SeaPRwire.com) – On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13.02% year-on-year to RMB 31.63 […]

Brisbane, Australia–(ACN Newswire via SeaPRwire.com – March 25, 2026) – Adyton Resources Corporation (TSXV: ADY) (“Adyton” or the “Company“) is pleased to announce positive expansionary drill results from its ongoing exploration program at the 100% owned Fen […]